Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
eFFECTOR Therapeutics, Inc. (EFTR) had Weighted-Average Shares Outstanding (Diluted) of 4.08M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
$-8.83M |
|
-- |
|
-- |
|
$8.40M |
|
$-8.40M |
|
$-0.44M |
|
$-8.83M |
|
$-8.83M |
|
$-8.83M |
|
$-8.83M |
|
$-8.83M |
|
$-8.83M |
|
$-8.40M |
|
$-8.43M |
|
4.08M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
4.08M |
$-2.16 |
|
$-2.16 |
|
| Balance Sheet Financials | |
$26.25M |
|
$0.19M |
|
$0.88M |
|
$27.13M |
|
$25.57M |
|
-- |
|
$0.73M |
|
$26.30M |
|
$0.83M |
|
$0.83M |
|
$0.83M |
|
3.90M |
|
| Cash Flow Statement Financials | |
$-7.28M |
|
$-6.32M |
|
$14.23M |
|
$14.88M |
|
$15.51M |
|
$0.63M |
|
$1.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.03 |
|
-- |
|
-- |
|
-- |
|
22.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.28M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1068.20% |
|
-1068.20% |
|
-32.56% |
|
-1068.20% |
|
$0.21 |
|
$-1.78 |
|
$-1.78 |
|